APA (7th ed.) Citation

Illini, O., Lang-Stöberl, A. S., Fabikan, H., Weinlinger, C., Valipour, A., & Hochmair, M. J. Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report. Elsevier.

Chicago Style (17th ed.) Citation

Illini, Oliver, Anna Sophie Lang-Stöberl, Hannah Fabikan, Christoph Weinlinger, Arschang Valipour, and Maximilian J. Hochmair. Very First Real-world Data on Zongertinib Use in Non-small Cell Lung Cancer Patients with HER2 Mutations: A Brief Report. Elsevier.

MLA (9th ed.) Citation

Illini, Oliver, et al. Very First Real-world Data on Zongertinib Use in Non-small Cell Lung Cancer Patients with HER2 Mutations: A Brief Report. Elsevier.